Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(10):769-771; doi:10.1093/jnci/94.10.769
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplemental Information
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Malone, T.
Right arrow Articles by Giantonio, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malone, T.
Right arrow Articles by Giantonio, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 10, 769-771, May 15, 2002
© 2002 Oxford University Press

BRIEF COMMUNICATION

High Rate of Consent to Bank Biologic Samples for Future Research: The Eastern Cooperative Oncology Group Experience

Thomas Malone, Paul J. Catalano, Peter J. O'Dwyer, Bruce Giantonio

Affiliations of authors: T. Malone, Eastern Cooperative Oncology Group, Boston, MA; P. J. Catalano, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston; P. J. O'Dwyer, B. Giantonio, University of Pennsylvania, Philadelphia.

Correspondence to: Thomas Malone, M.P.A., Eastern Cooperative Oncology Group, 900 Commonwealth Ave., 2nd Floor, Boston, MA 02215 (e-mail: tmalone{at}partners.org).

ABSTRACT

The Eastern Cooperative Oncology Group (ECOG) requires patient consent for the storage and future use of samples left over from its therapeutic cancer clinical trials. The ECOG consent instrument evolved from a simple statement requiring a signature to a more detailed three-question format. Between February 1998 and October 2000, more than 7000 patients were accrued to studies using one of the two consent forms. We analyzed our consent response data by consent type, demographic information, disease site, and institution type to determine the assent rates for future storage and research on biologic samples and to identify possible factors predicting patient refusal. The assent rate for the original banking consent statement was 89.4%, whereas that for the more detailed consent form was 93.7%. Higher assent rates were statistically significant for the detailed consent form versus the original consent form (P= .001), for community-based practices versus academic centers (P<.001), and for patients aged at least 65 years versus those younger (P= .002). The results show that increased patient protection does not result in decreased availability of biologic samples for future research purposes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
E Vermeulen, M K Schmidt, N K Aaronson, M Kuenen, P van der Valk, C Sietses, P van den Tol, and F E van Leeuwen
Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment
J. Clin. Pathol., March 1, 2009; 62(3): 275 - 278.
[Abstract] [Full Text] [PDF]

Home page
 J Health Serv Res PolicyHome page
S. Treweek, A. Doney, and D. Leiman
Public attitudes to the storage of blood left over from routine general practice tests and its use in research
J Health Serv Res Policy, January 1, 2009; 14(1): 13 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Public HealthHome page
A. Kettis-Lindblad, L. Ring, E. Viberth, and M. G. Hansson
Genetic research and donation of tissue samples to biobanks. What do potential sample donors in the Swedish general public think?
Eur J Public Health, August 1, 2006; 16(4): 433 - 440.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
D. Wendler
One-time general consent for research on biological samples.
BMJ, March 4, 2006; 332(7540): 544 - 547.
[Full Text] [PDF]

Home page
 aacredbookHome page
R. L. Aamodt, R. Hakimian, and M. Bledsoe
Human Specimen Research: Regulation, Policy, and Ethical Issues
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 319 - 322.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
D. T. Chen, D. L. Rosenstein, P. Muthappan, S. G. Hilsenbeck, F. G. Miller, E. J. Emanuel, and D. Wendler
Research With Stored Biological Samples: What Do Research Participants Want?
Arch Intern Med, March 28, 2005; 165(6): 652 - 655.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. J. Goebell, S. Groshen, B. J. Schmitz-Drager, R. Sylvester, M. Kogevinas, N. Malats, G. Sauter, H. B. Grossman, C. P.N. Dinney, F. Waldman, et al.
Concepts for Banking Tissue in Urologic Oncology--The International Bladder Cancer Bank
Clin. Cancer Res., January 15, 2005; 11(2): 413 - 415.
[Full Text] [PDF]

Home page
 NEJMHome page
D. E. Winickoff and R. N. Winickoff
The Charitable Trust as a Model for Genomic Biobanks
N. Engl. J. Med., September 18, 2003; 349(12): 1180 - 1184.
[Full Text] [PDF]

Home page
 BMJHome page
P. J van Diest and J. Savulescu
For and against: No consent should be needed for using leftover body material for scientific purposes * For * Against
BMJ, September 21, 2002; 325(7365): 648 - 651.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.